National Guideline Clearinghouse | Functional outcomes assessment for cervical degenerative disease.

Guideline Title
Functional outcomes assessment for cervical degenerative disease.

Bibliographic Source(s)
Holly LT, Matz PG, Anderson PA, Groff MW, Heary RF, Kaiser MG, Mummaneni PV, Ryken TC, Choudhri TF, Vresilovic EJ, Resnick DK, Joint Section on Disorders of the Spine and Peripheral Nerves [trunc]. Functional outcomes assessment for cervical degenerative disease. J Neurosurg Spine 2009 Aug;11(2):238-44. [30 references] PubMed

Guideline Status
This is the current release of the guideline.


full-text:
National Guideline Clearinghouse | Functional outcomes assessment for cervical degenerative disease.






J Neurosurg Spine. 2009 Aug;11(2):238-44.

Functional outcomes assessment for cervical degenerative disease.

Holly LT, Matz PG, Anderson PA, Groff MW, Heary RF, Kaiser MG, Mummaneni PV, Ryken TC, Choudhri TF, Vresilovic EJ, Resnick DK; Joint Section on Disorders of the Spine and Peripheral Nerves of the American Association of Neurological Surgeons and Congress of Neurological Surgeons.

SourceDivision of Neurosurgery, David Geffen School of Medicine, University of California at Los Angeles, California, USA.

Abstract
OBJECT: The objective of this systematic review was to use evidence-based medicine to identify valid, reliable, and responsive measures of functional outcome after treatment for cervical degenerative disease.

METHODS: The National Library of Medicine and Cochrane Database were queried using MeSH headings and key words relevant to functional outcomes. Abstracts were reviewed after which studies meeting inclusion criteria were selected. The guidelines group assembled an evidentiary table summarizing the quality of evidence (Classes I-III). Disagreements regarding the level of evidence were resolved through an expert consensus conference. The group formulated recommendations that contained the degree of strength based on the Scottish Intercollegiate Guidelines network. Validation was done through peer review by the Joint Guidelines Committee of the American Association of Neurological Surgeons/Congress of Neurological Surgeons.

RESULTS: Myelopathy Disability Index, Japanese Orthopaedic Association scale, 36-Item Short Form Health Survey, and gait analysis were found to be valid and reliable measures (Class II) for assessing cervical spondylotic myelopathy. The Patient-Specific Functional Scale, the North American Spine Society scale, and the Neck Disability Index were found to be reliable, valid, and responsive (Class II) for assessing radiculopathy for nonoperative therapy. The Cervical Spine Outcomes Questionnaire was a reliable and valid method (Class II) to assess operative therapy for cervical radiculopathy.

CONCLUSIONS: Several functional outcome measures are available to assess cervical spondylotic myelopathy and cervical radiculopathy.

PMID:19769503[PubMed - indexed for MEDLINE]
Functional outcomes assessment for cervical degene... [J Neurosurg Spine. 2009] - PubMed result